As the Senior Director of Biosimilars, Sean McGowan is responsible for leading strategy and business development initiatives for the Biosimilar product category at AmerisourceBergen. As the Biosimilar market continues to expand, Sean partners with Biosimilar manufacturers in the pre-commercial, launch and post-launch phases to ensure the successful launch and growth of these products. Additionally, he leads the internal collaboration with AmerisourceBergen’s customer groups to guarantee open access to Biosimilar products for the organization’s customers and patients.

Sean has over a decade of experience in the healthcare industry, including the pharmaceutical, specialty pharmaceutical and patient services areas of focus. He joined AmerisourceBergen in 2017 as part of the organization’s Strategic Global Sourcing team, focusing on brand and specialty pharmaceutical distribution initiatives. Prior to joining AmerisourceBergen, Sean held commercial, strategic account management and business development positions at AstraZeneca, Endo Pharmaceuticals and Accolade, Inc. 

Sean graduated from the Fox School of Business at Temple University with a Master of Business Administration degree and received his undergraduate degree from Dickinson College.